文献速递瓣膜病与结构性心脏病血脂与心血管预防

中国云南不同海拔社区人群瓣膜性心脏病患病率、谱系及病因研究

Prevalence, spectrum and aetiology of valvular heart disease based on community echocardiographic screening transition from different altitudes in Yunnan, China.
PubMed 文献 · Heart · 2025-10-29

在云南开展两项社区超声心动图筛查,纳入5059名35岁及以上居民,比较不同海拔组瓣膜性心脏病的患病率与病因。总体患病率36.7%,临床显著者2.5%;海拔≥2000米各组患病风险均高于<2000米组,高海拔以功能性病因为主。

要点

  • 云南社区35岁及以上人群总体瓣膜性心脏病患病率为36.7%。
  • 海拔2000–2499米、2500–2999米及≥3000米组患病风险均高于<2000米组。
  • 海拔≥3000米组临床显著瓣膜性心脏病以功能性病因为主,<3000米组以退行性为主。

核心结论

  • 高海拔地区成人瓣膜性心脏病患病风险更高,且不同海拔间疾病特征和病因存在显著差异。

研究设计与样本

  • 在云南省开展两项序贯社区超声心动图筛查,纳入5059名35岁及以上合格参与者。
  • 采用稳健方差的多变量泊松回归模型评估不同海拔组与瓣膜性心脏病及其亚型的关联。

主要发现

  • 总体瓣膜性心脏病、临床显著瓣膜性心脏病和临床显著反流性瓣膜性心脏病的患病率分别为36.7%、2.5%和2.4%。
  • 按海拔分层,<2000米、2000–2499米、2500–2999米和≥3000米组任何瓣膜性心脏病患病率分别为30.4%、40.9%、35.0%和44.3%。
  • 完全调整模型显示,与<2000米组相比,2000–2499米、2500–2999米和≥3000米组瓣膜性心脏病患病率比分别为1.28(95%CI 1.15–1.42)、1.20(95%CI 1.02–1.41)和1.34(95%CI 1.04–1.72)。
  • 海拔<3000米组临床显著瓣膜性心脏病病因以退行性为主,≥3000米组以功能性最常见。
  • 亚组分析识别出男性、少数民族、60岁及以上和高收缩压等高风险人群。

临床怎么用

  • 在高海拔社区中,对男性、少数民族、60岁及以上及高收缩压人群可考虑加强瓣膜性心脏病的早期筛查。
  • 临床评估瓣膜性心脏病病因时需结合海拔背景,高海拔地区应关注功能性病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The burden of valvular heart disease (VHD) is rising rapidly globally, accompanied by substantial geographical disparities. Although altitude may influence cardiovascular system, no community-based studies have yet explored altitudinal differences in VHD epidemiology. OBJECTIVE: This study aims to investigate the prevalence, spectrum and aetiology of VHD in different altitude areas. METHODS: We conducted two sequential community-based echocardiography screening programmes in Yunnan Province of China and included 5059 eligible participants aged 35 years and older. The multivariable Poisson regression models with robust variance were performed to assess the association of different altitude groups with VHD and its subtypes. RESULTS: The prevalence of overall VHD, clinically significant VHD and clinically significant regurgitant VHD was 36.7%, 2.5% and 2.4%, respectively. After stratification by altitude, the prevalence of any VHD among participants in the <2000 m, 2000-2499 m, 2500-2999 m and ≥3000 m groups was 30.4%, 40.9%, 35.0% and 44.3%, respectively. The fully adjusted models showed that the prevalence ratios for VHD in the 2000-2499 m, 2500-2999 m and ≥3000 m groups were 1.28 (95% CI 1.15 to 1.42), 1.20 (95% CI 1.02 to 1.41) and 1.34 (95% CI 1.04 to 1.72), compared with the <2000 m group. Clinically significant VHD in the <3000 m altitude group was predominantly degenerative in aetiology, whereas functionality was most prevalent in the ≥3000 m altitude group. Subgroup analysis identified some high-risk populations, including male, minority ethnicity, 60 years and older and high systolic blood pressure. CONCLUSIONS: Adults living at high altitudes have a higher prevalence risk of VHD; significant altitudinal differences exist in the characteristics and aetiology of VHD. The findings could provide insights into primary prevention and early screening for VHD in low- and middle-income countries where a majority of the population lives at high altitudes.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Pang L, Xia Y, Tang M, et al. Prevalence, spectrum and aetiology of valvular heart disease based on community echocardiographic screening transition from different altitudes in Yunnan, China. Heart. 2025. PMID: 40032496. doi:10.1136/heartjnl-2024-325221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。